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Abstract – Small ruminant lentiviruses (SRLV = maedi-visna in sheep and caprine arthritis
encephalitis in goats) are distributed throughout most countries of the world, particularly Europe.
Laboratories from 16 European countries established collaborations within the framework of a
COST (CO-operation in the field of Scientific and Technical Research) action sponsored by the
European Union in order to (i) better organize their research programmes on SRLVs and (ii) to
coordinate efforts to combat these two diseases. After five years, a consensus conference – the first
one in the veterinary medicine field – concluded the work of this network of laboratories by
reviewing the present position and discussing three important questions in the field of SRLVs:
routes of transmission, consequences of infection and potential role of eradication programmes at
either a European or local level, according to the situation in each country or region. This paper
brings together existing information regarding these questions and identifies areas for future
research.
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1. INTRODUCTION
Infections caused by small ruminant len-
tiviruses (SRLVs), comprising maedi-visna
virus (MVV) initially isolated in sheep and
caprine arthritis encephalitis virus (CAEV)
initially isolated in goats, are widespread in
many countries [10, 17, 26, 30, 32, 37, 40,
44, 67, 69, 97, 106, 108, 115, 127, 133, 138,
148]; SRLVs are responsible for significant
economic losses that have led to the devel-
opment of control programmes in Europe
and elsewhere. A European Co-operation in
the field of Scientific and Technical Research
(COST) action was initiated in 1998 to
coordinate research in 16 European coun-
tries. This review is a report of the discus-
sions held during the final meeting of this
COSTa action; it was organized as a con-
sensus conference for the purpose of iden-
tifying aspects of SRLV infections that are
generally accepted and to discuss those that
are open to debate due to a lack of scientific
evidence or to regional differences.
Three questions were addressed: (i) What
routes of transmission for infection by
SRLVs need to mainly be considered?
(ii) What are the consequences of SRLV
infections? (iii) Should a control policy be
implemented on a European or a local
scale?
2. THE ROUTES OF TRANSMISSION
Precise knowledge of the routes of trans-
mission is a critical component of control
programmes [120].
Colostrum and milk are considered of
prime importance in the transmission ofa
 http://ue.eu.int/cost 
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SRLVs from mother to offspring [35, 46,
55, 83, 87, 95, 115, 131]. This is also sup-
ported by the apparent success of eradica-
tion programmes in which offspring are
removed at birth and reared on bovine
colostrum and milk [29, 64, 115]. Particu-
larly in sheep, contact between ewe and
lamb also represents an important risk fac-
tor in viral transmission to the newborn [9,
66]. This may be explained by aerosol
transmission from the respiratory tract, the
lungs being a major target organ in this spe-
cies. Aerosol transmission between ani-
mals of all ages in close contact and over
distances of up to several meters appears to
be a significant route of spread both within
and between flocks and herds, particularly
under intensive housing or grazing condi-
tions [46].
The significance of intrauterine viral
transmission continues to be unclear [28,
33, 34]. Published evidence suggests that
intrauterine transmission may occur in up to
10% of fetuses born to infected dams [15].
The role of this route of vertical transmis-
sion is difficult to assess because the results
can vary depending on the methodology
employed and on the immune response to
the virus. If PCR is used to demonstrate
virus in the caesarean-derived foetus, the
nucleotide sequences of the amplicon
should be compared to the virus infecting
the dam. If serology is used, the long and
variable time to seroconversion may make
it difficult to establish that transmission has
been via the intrauterine route. Moreover,
any contact with infected animals must be
excluded. However, the success of eradica-
tion programmes based on removal at birth
and rearing on bovine colostrum and milk
suggests that intrauterine viral transmission
is generally of minor importance [65].
Placentas contaminated by maternal blood
may also represent a source of infection.
Semen has been demonstrated to contain
virus but its role in viral transmission has
not been studied [41, 100, 111, 141, 147].
However, virus-infected rams and bucks
can infect females by other routes.
Transmission by contaminated milking
machines or buckets is considered to be a
risk factor [2, 84].
Humans may also contribute to the
spread of infection by not changing cloth-
ing, boots and equipment when dealing
with infected and uninfected flocks [55].
Animals such as dogs or cats are unlikely
to play a role in viral transmission.
2.1. Methods of detection
A wide array of techniques is used to
detect SRLV infections. These are based on
the detection of either antibody or virus
[75].
Serological tests include agar gel immu-
nodiffusion (AGID), ELISAs, Western blot
and radioimmunoprecipitation.
Tests for virus include isolation in cell
culture and detection by cytopathic effect or
antigen staining, and genome detection by
PCR or RT-PCR. In situ hybridization is
useful in histopathological studies [68, 122].
Although now there is no universally
accepted gold standard to determine the
sensitivity and specificity of the tests used
for detecting SRLV infection, the success
of control programmes indicates that the
available tests are useful for reducing the
prevalence of infection. Radioimmunopre-
cipitation and Western blot are considered
good verification methods by most labora-
tories when using optimized antigen and
technical protocols. Radioimmunoprecipi-
tation is technically demanding and rarely
used. Western blotting is established more
widely as a routine standard for confirming
ELISAs [12, 61, 137].
2.1.1. Serological tests
Some aspects specific for SRLV infec-
tions influence the outcome of serological
tests. Estimates of the mean time from infec-
tion to seroconversion range from three
weeks to several months although some
animals may remain seronegative [70, 113,
132]. The mean time to seroconversion is
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shorter in heavily infected flocks than in
those with a low seroprevalence. In addi-
tion, animals with a low antibody titre may
transiently become seronegative [59, 61,
78].
Genome analyses have shown that
SRLVs are highly heterogeneous [6, 24, 86,
89, 98, 99, 139, 154]. This is also a notable
feature of MVV and CAEV strains. Indi-
vidual proteins of different SRLV strains
have immunodominant linear epitopes, some
of which are largely or strictly strain-spe-
cific [11, 56, 119]. Strain-specific epitopes
are found not only in the more variable enve-
lope proteins but also in the more conserved
Gag-encoded proteins [56]. Current findings
suggest that the immune reaction to these
epitopes may have a significant impact on
the sensitivity of serological tests. It is there-
fore advisable to use tests that can detect
antibodies to antigens of strains present in
the animal population under investigation.
2.1.1.1. Agar gel immunodiffusion
This test has been the classical method
for the detection of antibodies to lentivi-
ruses in domestic animals [1, 31, 39, 57, 76,
117]. It is considered to have a good specif-
icity but is generally less sensitive than
ELISA [114, 144]. It is technically simple
but its interpretation, being somewhat sub-
jective, requires experience [117, 137,
145].
2.1.1.2. ELISA
ELISAs are suitable for screening large
numbers of samples and are more sensitive
than AGID. An additional advantage is
the quantitative readout, which permits
computer-based analysis of raw data. A
large number of different antigens is used
to detect antiviral antibodies by ELISA.
These include whole virus, recombinant
proteins, and peptides containing immuno-
dominant epitopes [13, 19, 22, 42, 48, 60,
62, 63, 72, 80–82, 90, 103, 110, 112, 114,
117, 126, 145, 151, 155]. Biphasic tests are
preferable because they have a lower fre-
quency of non-specific reactions. Such
reactions may be caused by antibodies to
cellular components in whole virus ELI-
SAs, by glutathione-S-transferase, or by
bacterial constituents in the case of recom-
binant proteins.
Recently, synthetic peptides have been
used in ELISAs to detect antiviral antibod-
ies [81]. Preliminary results look promising
but knowledge of the SRLV strains present
in the population being tested, as well as the
selection of appropriate peptides are essen-
tial for the development of reliable tests.
2.1.1.3. Western Blot
Western Blotting is more sensitive than
ELISA and is used routinely as a confirm-
atory test for sera that give indeterminate
results in ELISA [14]. Currently, there is no
standardized protocol for performance or
interpretation of Western Blotting in SRLV
diagnostics (e.g. reaction to one versus two
or several bands, intensity of bands).
2.1.1.4. Other serological methods
Radioimmunoprecipitation and radioim-
munoassay are largely limited to experimen-
tal work and these methods are not consid-
ered as routine diagnostic procedures [51,
77].
2.1.1.5. Recommendations on serology
The most sensitive and specific test should
be used for SRLV serology. To facilitate large
sample throughput and objective interpre-
tation, it is advisable to use a proven ELISA.
Due to the heterogeneity of viral strains,
care should be taken when selecting the
antigen. Specifically, the antigen should
contain epitopes present in the virus strains
circulating in the population being investi-
gated. The results of the flock test should
be considered when interpreting the results
of individual animals [3]. Where validated,
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milk may be used instead of serum for anti-
body detection [72, 94, 155].
2.1.2. Virus detection
Critical aspects of viral detection are
(i) the body part and tissue sampled; (ii) the
viral load at the time of sampling; (iii) the
biological properties and genetic composi-
tion of the virus. 
The most common material collected for
virus detection is blood. The low viral load
in blood is a major challenge for virus detec-
tion. In addition, as shown in goats experi-
mentally infected with CAEV and in sheep
infected with MVV, the viral load may fluc-
tuate over time and may differ between
individual animals [70, 156].
2.1.2.1. Virus isolation in cultured cells
This is the classical method of demon-
strating the presence of a virus. The best
results are obtained by co-culturing the test
sample (ex: peripheral blood mononuclear
cells or monocytes) with SRLV-free sus-
ceptible cells such as goat synovial mem-
brane cells for CAEV and sheep chorioid
plexus cells or skin fibroblasts for MVV
[124]. Microscopic examination for the
appearance of a cytopathic effect (presence
of syncytia) in these sensitive cells is com-
monly used to confirm the presence of
virus. Due to the existence of SRLVs with
a low cytopathic potential, it is advisable to
stain the cells for the presence of viral anti-
gen. This may be combined with the meas-
urement of reverse transcriptase activity
and PCR [76].
2.1.2.2. PCR
Theoretically, this technique has the
advantage of detecting infection in animals
before seroconversion [8, 23, 68, 146, 152,
153]. For years, numerous groups have
attempted to establish PCR as a diagnostic
method for SRLV infection, with variable
results, such as the finding of amplicons in
some seronegative animals and vice versa
[20]. The former may represent animals
before seroconversion [68,113], or long-
term seronegative carriers, while the latter
suggests that the PCR protocols may have
lacked sensitivity. The reasons for this may
be due to a combination of low viral load
and of the use of primers that failed to detect
all strains of SRLVs. To overcome the latter
problem, efforts should be made to deter-
mine the sequences of as many SRLV
strains as possible. This is important for
improving the performance of PCR as a
diagnostic test and is a prerequisite for the
establishment of molecular techniques to
study the epidemiology of infection [85,
118, 125, 154].
2.1.2.3. Recommendations on virus 
detection
At present, virus detection by co-culture
and PCR should not be considered as alter-
natives to serology, but as complementary
tests for use in selected cases [47]. How-
ever, PCR protocols of use for a wide spec-
trum of strains and geographical areas are
currently being developed. The sensitivity
of virus isolation techniques by co-culture
should always be confirmed by including a
field strain at limiting dilution in parallel to
the field sample being examined. The sen-
sitivity of PCR can be enhanced by using
nested or semi-nested methods for sequence
amplification. Appropriate positive and neg-
ative controls should be included and strict
control of contamination is essential. If nec-
essary, the best control method is to sequence
the amplicons obtained in positive test sam-
ples and to demonstrate that the sequence
obtained is different from SRLV used in the
laboratory.
2.2. The risk of live animal trading
Live animals trading is considered a
major risk factor in the spread of SRLV
infection between herds [25].
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2.3. The role of derived products 
in viral transmission 
As outlined in previous sections of this
document, milk and colostrum as well as
semen have been shown to contain virus.
The placenta has also been considered in the
context of the intrauterine transmission of
SRLVs [2, 50]. A recent study has demon-
strated the presence of CAEV-infected cells
in the goat genital tract which suggests the
potential role of this tract for vertical trans-
mission of CAEV from doe to embryo or
fetus [49]. Data on the virus content of ovo-
cytes are not available.
Cheese is unlikely to be involved in viral
transmission.
3. THE CONSEQUENCES OF SRLV 
INFECTION
“Maedi-visna” (MV) refers to pneumo-
nia (Icelandic “maedi”) and encephalitis
(“visna”), which together with mastitis char-
acterize lentiviral infection in sheep [129,
130]. The introduction of lentivirus-infected
Karakul rams from Germany to Iceland in
1933 not only led to an epizootic in the
indigenous breed of sheep in Iceland but
culminated in the first isolation of lentivi-
ruses and a description of the clinical signs
of infection [101]. Knowledge of the viral
cause of caprine arthritis-encephalitis (CAE)
in goats is more recent. The disease was
known to goat owners as “big knees” (i.e.
enlargement of the carpal joints) long before
the first isolation of the virus in the USA in
1980 from arthritic goats that had previ-
ously suffered from encephalitis [27]. In
contrast to the epizootic nature of the out-
break of MV in Iceland and due to vertical
transmission, CAE was originally believed
to be a hereditary disease in the heavily
infected regions of central Europe.
Knowledge of animal welfare and of
economic consequences may determine if,
and by what means, control or eradication
of lentiviral infection is a priority in sheep
and goat farming.
3.1. Economic consequences
The general consensus was that eco-
nomic losses due to SRLV infection are sig-
nificant. However, analysis of the literature
indicated that information on such losses is
incomplete and in some instances contra-
dictory. The reasons for this are complex
and involve the interaction of SRLVs with
their hosts as well as management factors
[136]. Factors influencing economic losses
are the following: (i) clinical disease caused
by SRLV infection develops slowly; (ii) only
about 30% of infected animals develop
clinical disease; (iii) disease signs and eco-
nomic losses are related to seroprevalence,
with no signs evident in herds with low
prevalence of infection; (iv) genetic factors
influence the extent of disease (in sheep,
susceptibility to disease may be influenced
by breed whereas in goats this is associated
with certain major histocompatibility hap-
lotypes present in all breeds investigated);
(v) certain management practices such as
milk production, or housing and keeping
animals in crowded conditions increase the
rate of viral transmission and hence sero-
prevalence [73]; (vi) disease signs may be
influenced by concurrent infections which
may vary with different geographic areas
and management practices. For example,
co-infection by maedi visna and Jaagsiekte
retrovirus, which causes ovine pulmonary
adenocarcinoma, a contagious lung tumor,
results in aggravated disease [52, 149].
Analysis of the literature showed that
SRLV infection influences the following
production-related parameters.
3.1.1. Milk production
Milk production can be decreased by an
estimated 10% – due to indurative mastitis,
which is often a feature of SRLV infection
[79, 135, 136]. Precise data are unavailable
because standardized procedures to assess
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milk production are less common in small
ruminants than in dairy cattle. It should be
noted that reduced milk production is influ-
enced by husbandry practices [109]. The
lower weight gain in offspring born to
infected dams and demonstrated in most
studies, indicates that losses have an impact
on the productivity of the following gener-
ation [54].
3.1.2. Birth weight
There is evidence [54] or no evidence [7,
136] that SRLV infection decreases the
birth weight. Low birth weight is known to
negatively affect the development of lambs
and kids, thus lowering productivity, par-
ticularly in heavily infected flocks [74].
3.1.3. Weight gain
Infection with SRLVs decreases the
weight gain of lambs (presumably due to
depressed milk yield from indurative mas-
titis [105]) [38, 45, 54]. Losses may range
from 0.3 to 3.0 kg per lamb at weaning [7,
74, 104, 105].
3.1.4. Mortality rates
Mortality due to SRLV infection is low
in enzootic areas, but is strongly influenced
by concurrent disease, husbandry, nutrition
and environmental factors. Observations
made during the epizootic of MV in Iceland
show that mortality may reach 20–30% in
newly infected animals [128, 129]. SRLV
infection decreases the average life span of
animals due to decreased productivity. The
effect of premature culling, typically a year
earlier than uninfected animals, is generally
underestimated [5]. It also affects produc-
tivity indirectly by decreasing the average
number of offspring born to each genera-
tion. Related to the decrease in milk pro-
duction is an increase in lamb mortality.
Alternatively feeding with bovine colos-
trum may increase lamb mortality due to
haemolytic anaemia if the source cow is not
well chosen.
An element that has not received much
attention in the past is the impact of SRLV
infection on the quality of production. Infec-
tion may negatively affect quality by increas-
ing somatic cell counts in the milk. As
consumers increasingly demand products
from animals with the best health status
possible, animals persistently infected with
SRLVs may not meet this requirement.
3.2. Animal welfare consequences
The term “animal welfare” is used in
relation to aspects of SRLV infection that
directly affect the quality of life of the ani-
mals. Factors that primarily affect produc-
tivity without causing obvious pain or dis-
comfort are not included in this definition.
It is obvious that this distinction is difficult
and may be subject to cultural differences
and individual opinions. However, the con-
sensus was reached that SRLV infection
has a significant impact on animal welfare
because the quality of life of clinically
affected animals is reduced due to pain and
disability.
Originally, MVV and CAEV were con-
sidered two distinct yet closely related
viruses which infect sheep and goats,
respectively. As will be seen below, these
viruses are not strictly host-specific. It is the
consensus that MVV and CAEV share the
same target organs. Both viruses affect the
mammary gland equally [143]. However,
their predilection for some other organs is
different. Lung and brain are classical tar-
gets for MVV [93], whereas joints appear
to be the most commonly affected organs in
CAEV infection. In contrast to MV, encepha-
litis is typically – although rarely – observed
in young kids. Although weight loss and ill
thrift are features of SRLV infection, actual
emaciation is less common. When consid-
ering SRLV infection, it is important to
emphasize that usually only a minority of
infected animals develop clinical signs. There
was consensus that immunosuppression is
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not a feature of SRLV infection probably
because, in contrast to the immunodefi-
ciency-causing lentiviruses, SRLVs do not
infect lymphocytes [16, 53]. Genetic fac-
tors of both the host (breed- and family-
associated disease susceptibility) and the
virus (virulence) influence the outcome of
SRLV infection [36, 123].
3.3. Virulence of SRLVs
“Virulence” refers to the ability of a
pathogen to cause disease. Information on
the virulence of SRLVs is scant. It was
noted in Iceland that certain strains of MVV
are neurotropic and this was recently found
to be correlated with a change in the LTR
region of the viral genome [4]. Lentiviruses
are genetically unstable, with a high rate of
genome evolution typical of RNA viruses
and subject to genetic recombination with
viruses of identical or closely related spe-
cies. However, there is no evidence from
clinical and epidemiological data that SRLVs
may evolve rapidly in vivo, nor is there evi-
dence for recombination between MVV
and CAEV in vivo. In fact, evolution of
SRLVs in infected animals is approxi-
mately 10 times slower than that of HIV in
humans. This may be because the viral load
of SRLVs in infected animals is lower than
that of immunodeficiency-causing lentivi-
ruses. Therefore, the latter should not be
regarded as models for SRLVs in this
regard [91]. There is also no evidence that
the higher disease incidence observed in
heavily SRLV-infected flocks may be
related to a higher virulence, because reduc-
ing the seroprevalence decreases the prev-
alence of disease.
3.4. The risk of the transmission 
of SRLVs to other species
Early reports suggested that MVV and
CAEV could be transmitted experimentally
to goats and sheep, respectively, but con-
cluded that such a transfer was unlikely
under natural conditions. However, in the
light of several recent reports this conclu-
sion cannot be upheld. Using phylogenetic
sequence analyses, several reports clearly
demonstrate that MVV can infect goats, and
CAEV can infect sheep [18, 150]. It is
unclear how infection crosses the species
barrier [21, 71, 102, 116, 142]. The most
likely risk factors are ingestion of virus-
contaminated ovine colostrum and milk by
goats and vice versa, as well as a close con-
tact between the species in overstocked
barns. It is unclear at what rate these viruses
spread within the “heterologous” host pop-
ulation, but there was consensus that SRLV
infection across the species barrier must be
taken into account in control programmes.
Specifically, the same regulations should
apply to both MV and CAE, and control
programmes that only target sheep or goats
alone are no longer acceptable.
There is serological evidence of SRLV
infection in wild ruminants such as mouf-
flon, ibex and chamois [92]. The prevalence
of SRLV infection is difficult to determine
in these species. It is also unclear whether
the viruses responsible for the SRLV-spe-
cific antibodies in these species originated
from domesticated small ruminants, or
form a cluster of their own. Preliminary evi-
dence suggests that SRLVs in these species
may be different from MVV and CAEV
(Chebloune Y., personal communication).
To date, no such viruses have been isolated
from sheep and goats, which suggests that
“exotic” SRLVs are not a cause of concern
for domestic small ruminants. Moufflon
and ibex are the closest relatives of sheep
and goats respectively, which may explain
the existence of SRLVs in these species
[58]. There is no evidence that, under nat-
ural conditions, SRLVs can infect species
such as cattle that are not closely related to
sheep and goats.
Recently, the zoonotic potential of viruses
of domestic animals has been intensively
scrutinized particularly because of the
zoonotic origins of HIV and new variant
Creutzfeldt-Jacob disease [96]. There was
a clear consensus that transmission of these
Maedi-visna and CAEV infections in small ruminants 265
agents must not be confused with SRLVs.
This consensus was based on the following
arguments: (i) there is no evidence that dis-
eases caused by SRLV in sheep and goats
are new; (ii) although small ruminants have
been domesticated for several thousand
years and have lived in close contact with
man, there is no epidemiological evidence,
either clinical or serological, for SRLV
infection in humans. A recent study has
shown that in some goats infected with
CAEV, antibodies can recognize linear
epitopes on HIV gp120 [88].
In summary, it was the view of the con-
ference that, based on the present knowl-
edge, SRLV do not present a risk to man.
4. THE NEED FOR A CONTROL 
POLICY TO BE IMPLEMENTED 
ON A EUROPEAN OR LOCAL 
SCALE
Due to the increased role of free trade of
live animals, embryos and semen in the EU,
this issue is of key importance in national
or regional control programmes. Several
parameters must be considered if the best
strategy is to be chosen, as indicated below.
4.1. The size and distribution of small 
ruminant populations in Europe
In December 2000, the sheep population
of the EU was 96.5 million and the goat
population 11.5 million. The population
varied markedly in different countries. For
instance, there were nearly 30 million sheep
in the UK and 24 million in Spain, whereas
the number in Germany was 2.15 million.
Nearly half of the 11.5 million goats were
in Greece and only 77 000 in England.
4.2. The incidence of SRLVs in different 
regions
In contrast to the census data, informa-
tion on the prevalence of SRLVs in the
sheep and goat population of Europe is less
updated. In some countries, information
dates from 2000 whereas in others the latest
figures are from 1978. Assuming an aver-
age small ruminant generation time of four
years, the latter information reflects the
prevalence in animals six generations ago.
Furthermore, in view of differences in sen-
sitivity and specificity of diagnostic tests
and varying sampling methods used, the
data on the prevalence of SRLVs in differ-
ent countries cannot be directly compared
at present. However, the data clearly show
that no European country can be considered
to be free of SRLV infection as defined by
the Office International des Epizooties
(< 1% of herds infected, probability 99%).
A notable exception is Iceland which erad-
icated MV following the epizootic initiated
by the importation of MVV-infected rams.
4.3. Transmission between different 
regions
Transmission of SRLVs has occurred
repeatedly between different regions. The
export of European breeds of goats and
sheep has resulted in the spread of SRLVs
to various parts of the world [25, 140]. In
contrast, certain indigenous goat breeds
that have had no contact with imported goat
breeds, such as Toggenburg and Saanen in
Europe or Criollo in Mexico [140], are free
of CAE. Phylogenetic evidence for the
introduction of SRLVs via live animal trade
is provided by the similarity of the South
African sheep lentivirus with European
strains such as the Scottish EV1. This
reflects the historical role played by
imported European sheep in the establish-
ment of the South African sheep industry.
The best known example of importation of
disease via live animal trade is Iceland.
SRLVs were also transmitted via live ani-
mal trade from Denmark to Norway, Scot-
land to Canada [44], England to Hungary
[138], Holland to France and Sweden to
Finland.
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4.4. The results of the various 
eradication schemes
Control programmes have been initiated
in many countries [120]. The European pio-
neer in the control of SRLVs was the Neth-
erlands, where the eradication of MV in
breeding flocks was initiated in the early
1980’s [65]. This successful programme
provided much information on the methods
that could be applied to control SRLVs, not
only in sheep but also in goats. Similar pro-
grammes were introduced in France, Italy,
Germany, Spain, Finland and Switzerland
[107, 134]. The removal of serologically
positive animals, as well as the separation
of lambs and kids of seropositive dams
immediately at birth for rearing on serolog-
ically negative or bovine colostrum have
been important features of successful CAE
eradication programmes [9, 121]. The sep-
aration of seronegative from seropositive
flocks and the strict control of live animal
trade are other important measures adopted.
The prevention of contact is also necessary
during transhumance. This husbandry prac-
tice, in which livestock are moved to another
climatic region such as grazing areas in the
mountains in summer, plays an important
role in some European countries.
All programmes were initiated voluntar-
ily and highlighted the crucial role played
by motivated sheep and goat owners as well
as their organizations [43]. Official health
authorities were more reluctant to introduce
SRLV controls. The main reason was the
cost and the lack of appropriate legislation.
In Switzerland, CAE eradication started
voluntarily in 1984 when it was realized
that the seroprevalence was 60 to 80%.
Federal, and in some instances, regional
authorities supported the efforts by funding
research projects for studying the epidemi-
ology and improving diagnostic methods.
Since 1998 “CAE-free” status has been
legally recognized. Seroprevalence in the
goat population has decreased to around 1%
and disease is no longer seen.
5. FINAL RECOMMENDATIONS
5.1. Recommendations on the policy 
of SRLV control
SRLV infections are a concern for all
European countries, irrespective of the cur-
rent prevalence. Those countries with a
very low prevalence aim to maintain this
status or even become officially free of
infection, while others aim to improve the
situation by reducing the seroprevalence. 
The consensus reached was the follow-
ing. Europe should embark on a control pro-
gramme with the aim of eventually eradi-
cating the virus. The control programmes
implemented in the different countries
should take into account the national and
regional differences and aim to maintain
the gene pool of sheep and goat breeds in
Europe. The stages of SRLV control lead-
ing to eradication are the following: (1) deter-
mine the prevalence of SRLVs by surveys
and other sources of data; (2) reduce high
seroprevalence to low seroprevalence thus
decreasing the prevalence of disease;
(3) reduce low seroprevalence to serologi-
cally negative thus eradicating disease;
(4) consolidate the serologically negative
status and eradicate the virus.
Each participating country should estab-
lish a national SRLV reference laboratory.
The main tasks of these laboratories should
be to: (1) advise on the national strategy for
SRLV control adapted to the epidemiolog-
ical situation and to the regional conditions;
(2) decide on the diagnostic tests for the
regional laboratories; (3) decide on the sta-
tus of results that cannot be resolved by the
regional laboratories; (4) organize national
ring tests to bring the regional laboratories
to the same level of quality; (5) advise the
national and regional authorities responsi-
ble for animal health on all matters relevant
to SRLV control, including the information
policy for the goat and sheep farming indus-
try; (6) participate in ring tests organized by
the conference of the national reference lab-
oratories within Europe; (7) participate in
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the European conference of the national ref-
erence laboratories (see below).
The individual programmes should include
the following points: (1) MV and CAE should
not be treated as separate entities  but com-
bined; (2) SRLV-infected and -free flocks
should not be kept on the same farm; (3) ani-
mal traffic should be regulated; (4) testing
should be performed by accredited labora-
tories.
Individual countries should draft legis-
lation supporting the eradication.
The EU should support the eradication
programme by: (1) sponsoring research aimed
at improving knowledge on pathogenesis,
epidemiology, prophylaxis and diagnostics
of SRLV infection; (2) sponsoring periodic
meetings of the national SRLV reference lab-
oratories (the conference of national SRLV
reference laboratories); thus (3) facilitating
exchange of knowledge and harmonization
of diagnostic procedures which are essen-
tial for open trade in Europe.
5.2. The public and control of SRLV 
infections
Sheep and goat owners are mostly una-
ware of the role of SRLVs in animal welfare
and economics of sheep and goat farming.
Countries are encouraged to pursue an
active information policy through pre-exist-
ing animal health information channels.
Researchers should support this by advising
the authorities on the pertinent aspects of
SRLV infection and by lecturing and pub-
lishing in periodicals produced for sheep
and goat farmers. Ideally, articles should
be co-authored by farming leaders. The
style should be easy to read and stimulate
interest and any statements that might sug-
gest a zoonotic dimension of SRLV infec-
tion should be avoided.
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